Zomig

Bayer

Pharma

Grünenthal buys up Nebido from Bayer for $500 million

Bayer has found a buyer for its hypogonadism drug Nebido but is keeping it in Germany as Grünenthal picks up its global rights for 500 million euros.

Kevin Dunleavy Jul 14, 2022 9:44am

The outline of a persons head with a lightning bold inside of it

AZ offloads headache drug Zomig to Grünenthal to raise cash

Jun 7, 2017 9:56am